Dusan VULETA, Gordana KOVACEVIC, Natasa NIKOLIC, Aleksandra JOVANOVIC-GALOVIC, Ivana HRNJAKOVIC-CVJETKOVIC, Aleksandra PATIC, Jelena RADOVANOV, Vesna MILOSEVIC

Frequency of twelve carcinogenic human papilloma virus types among women from the South Backa region, Vojvodina, Serbia

Background/aim: The aim of this study was to determine the presence and age distribution of different oncogenic human papilloma virus (HPV) types in women in the South Backa region and its relationship to Pap results. Materials and methods: In a group of 1087 women with normal and abnormal cytology, the commercial HR HPV Real-TM kit (Sacace Biotechnologies, Italy) was used. Results: Overall, 50.5% of the women were HPV positive. The presence of HPV types 18, 31, 51, and 58 was significantly influenced by age, while the presence of HPV types 16 and 45 was significantly influenced by cervical cytology. Results of the LSD test show a wide spectrum of high risk HPV among women with normal cytology and women with a low grade cervical lesion rate (atypical squamous cell of undetermined significance (ASCUS) and low grade squamous intraepithelial lesions (LSIL). The most prevalent HPV types found were 16, 31, 51, 18, and 52. In the HSIL group the most prevalent HPV types were 16 and 45. Conclusion: The reported results provide new data on the circulation of oncogenic HPV genotypes and frequency of multiple infections among women in Vojvodina and suggest that a prophylactic vaccine against HPV 16 and 18 has the potential to prevent approximately half of the high-grade lesions.

PDF

___

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 13741403.
3. Bruni L, Brotons M, Barrionuevo-Rosas L, Serrano B, Cosano R, Munoz J, Bosch FX, de Sanjosé S, Castellsagué X. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Serbia. Summary Report 2014-08-22. [Data Accessed].
4. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen HZ, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401: 7079.
5. IARC. Working Group on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 1995; 64: 1378.
6. IARC. A Review of Human Carcinogens. Pharmaceuticals, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2011; Part B of Volume 100. Lyon, France: International Agency for Research on Cancer; 2011: pp. 255313.
7. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157: 218226.
8. Stanley M. HPV-immune response to infection and vaccination. Infect Agent Cancer 2010; 5: 19.
9. Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, Bosch XF, de Sanjosé S. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer 2012; 7: 38.
10. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006; 24: S26S34.
11. de Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, Joura EA, Maldonado P, Laco J, Bravo IG et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 2013; 49: 34503461.
12. Wright TC, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 21202129.
13. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjos S, Franceschi S, Clifford GM. Human papillomavirus types in 115 789 HPVpositive women: A meta-analysis from cervical infection to cancer. Int J Cancer 2012; 131: 23492359.
14. Milosevic V, Jerant Patic V, Hrnjakovic Cvjetkovic I, Kovacevic G, Radovanov J. Genitalne infekcije izazvane Humanim papiloma virusima i njihova dijagnostika. In: Book of Abstracts of the 44th International Scientific Meeting; 2124 September, 2010; Nis, Serbia (in Serbian).
15. Rajovic J, Andrijevic Lj, Fajka R, Fenyvesi A, Malobabic D, Cuk D, Korovljev J, Kmezic V, Stajer L, Barisic A et al. The high-risk human papilloma virus types DNA test using hybrid capture technology in clinical practice. Arch Oncol 2007; 15: 2427.
16. Knezevic A, Aleksic G, Soldatovic I, Banko A, Jovanovic T. Cervical human papillomavirus infection in Serbia: risk factors, prevalence and genotype distribution in women with normal cervical cytology. Arch Biol Sci 2012; 64: 12771283.
17. Bruni L, Brotons M, Barrionuevo-Rosas L, Serrano B, Cosano R, Munoz J, Bosch FX, de Sanjosé S, Castellsagué X. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Croatia. Summary Report 2014-03-17. [Data Accessed].
18. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PTH, Muñoz N. Variations in the age specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119: 26772684.
19. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Muñoz N et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Brit J Cancer 2004; 90: 638 645.
20. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24: 4251.
21. Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202: 17891799.
22. Kondo K, Uenoyama A, Kitagawa R, Tsunoda H, KusumotoMatsuo R, Mori S, Ishii Y, Takeuchi T, Kanda T, Kukimoto I. Genotype distribution of human papillomaviruses in Japanese women with abnormal cervical cytology. Open Virol J 2012; 6: 277283.
23. Piana A, Sotgiu G, Cocuzza C, Musumeci R, Marras V, Pischedda S, Deidda S, Muresu E, Castiglia P. High HPV- 51 prevalence in invasive cervical cancers: results of a preimmunization survey in North Sardinia, Italy. PLoS One 2013; 8: e63395.
24. Petry KU, Luyten A, Justus A, Iftner A, Strehlke S, ReineckeLüthge A, Grunwald E, Schulze-Rath R, Iftner T. Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84-results of WOLVES, a populationbased epidemiological study in Wolfsburg, Germany. BMC Infect Dis 2013; 13: 135.
25. Mollers M, Boot HJ, Vriend HJ, King AJ, van den Broek IVF, van Bergen JEA, Brink AT, Wolffs FG, Hoebe JP, Meijer JL et al. Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands. Vaccine 2013; 31: 394401.
26. Yuce K, Pinar A, Salman MC, Alp A, Sayal B, Dogan S, Hascelik G. Detection and genotyping of cervical HPV with simultaneous cervical cytology in Turkish women: a hospitalbased study. Arch Gynecol Obstet 2012; 286: 203208.
27. Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996; 88: 13611368.
28. Milutin-Gasperov N, Sabol I, Halec G, Matovina M, Grce M. Retrospective study of the prevalence of high-risk human papillomaviruses among Croatian women. Coll Antropol 2007; 31: 8996.
29. Vujosevic D, Vuksanovic V, Poljak M, Jokmanovic N. Human papillomavirus genotype spectrum in studied group of Montenegrin women. Acta Medica (Hradec Kralove) 2012; 55: 130132.
30. Salimovic-Besic I, Hukic M. Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears. Epidemiol Infect 2015; 12: 19.
31. Andonovska J. Genotypic distribution and prevalence of the HPV infection in Macedonia. In: The 16th International Congress on Infectious Diseases (ICID); April 25 2014; Cape Town, South Africa: Abstract No: 60.023.
32. Ursu RG, Onofriescu M, Nemescu D, Iancu LS. HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania. Virol J 2011; 8: 558.
33. Kovachev S, Slavov V, Slavova K. Prevalence of human papillomavirus infection in women in some cities and regions of Bulgaria. J Med Virol 2013; 85: 15771584.
34. Filipi K, Tedeschini A, Paolini F, Celicu S, Morici S, Kota M, Bucaj E, De Marco F. Genital human papillomavirus infection and genotype prevalence among Albanian women: a crosssectional study. J Med Virol 2010; 82: 11921196.
35. Agorastos T, Lambropoulos AF, Sotiriadis A, Mikos T, Togaridou E, Emmanouilides CJ. Prevalence and distribution of high-risk human papillomavirus in Greece. Eur J Cancer Prev 2009; 18: 504509.
36. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11: 10481056.
37. Ho GY, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998; 78: 281285.
38. Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F et al. One virus, one lesionindividual components of CIN lesions contain a specific HPV type. J Pathol 2012; 227: 6271.